Mapping the efficiency of cancer care in Greece: findings from the All.Can Greece report

Cancer care efficiency in Greece remains one of the most complex and pressing challenges for the Greek health system — not only in terms of its clinical burden, but also in how care is organized around the patient.

With approximately 63,000 new cancer cases diagnosed annually and more than 32,000 cancer-related deaths each year, Greece faces a steadily increasing oncological burden. Projections suggest that cancer incidence will rise by around 23% by 2040, further intensifying pressure on health services.

Against this backdrop, All.Can Greece has published a landmark report titled “Mapping the Efficiency of Cancer Care in Greece”, based on the pilot implementation of the All.Can Action Guide for Efficient Cancer Care.

Rather than simply describing the current situation, the report aims to measure it — identifying where efficiency is lost across the cancer care pathway and where targeted reforms could make the greatest impact.

Cancer care efficiency in Greece: delays in care delivery

One of the most critical findings of the report relates to delays in the patient journey.

Despite the existence of modern infrastructure and highly specialized oncology centres, significant delays persist between initial suspicion, diagnosis, and the start of treatment.

These delays are not the result of a single bottleneck, but of systemic fragmentation:

  • fragmented referral pathways,
  • limited coordination between levels of care,
  • and the absence of standardized clinical protocols.

A key structural weakness is the lack of systematic monitoring of waiting times and time-to-treatment indicators. As a result, inefficiencies remain partially invisible to the system itself, limiting the ability to implement targeted improvements.

Fragmentation across the care continuum

The report highlights a broader issue of fragmentation in cancer care delivery.

The patient journey from primary care to specialist oncology services is often not clearly structured or consistently coordinated. Referral pathways depend heavily on individual practice rather than standardized national protocols.

A major gap is the absence of structured patient navigation services. In practice, this means that patients and families are often left to navigate a complex system on their own, increasing delays and adding unnecessary psychological burden.

At the same time, multidisciplinary tumor boards represent a positive development, supporting collaborative clinical decision-making across specialties. However, systematic monitoring of their performance remains limited.

The development of Comprehensive Cancer Centers is identified as a promising step forward, although further regulatory strengthening and clearer governance structures are still needed to maximize their impact.

Patient-centered care: progress with remaining gaps

Greece has made notable progress in collecting Patient-Reported Outcome Measures (PROMs) and Patient-Reported Experience Measures (PREMs), reflecting a growing commitment to integrating patient perspectives into care delivery.

However, patients’ access to their own clinical data remains limited, restricting their ability to actively participate in decision-making processes.

In addition, patient education and shared decision-making are not yet systematically embedded across the health system.

Another important gap concerns survivorship care. As cancer survival rates improve, the lack of structured long-term follow-up pathways leaves many patients without continuous support after active treatment ends.

Key policy directions

The report outlines several strategic priorities for improving cancer care efficiency in Greece:

  • Development of a comprehensive national cancer strategy with clear targets and governance mechanisms
  • Strengthening coordination across all levels of care
  • Implementation of standardized clinical pathways with defined time-to-treatment and quality indicators
  • Investment in oncology workforce capacity, particularly in shortage specialties
  • Establishment of structured patient navigation programmes
  • Acceleration of Comprehensive Cancer Center development
  • Systematic use of health data for monitoring performance and accountability
  • Greater patient engagement through PROMs, PREMs, and shared decision-making

Conclusion: a system with strong foundations but limited integration

Greece has many of the essential building blocks for a high-performing cancer care system — including infrastructure, clinical expertise, and emerging digital health capabilities.

However, the key challenge lies not in the existence of these components, but in their integration.

The All.Can Greece report highlights a system that is still operating in silos: strong individual elements that do not yet function as a fully connected care pathway.

In oncology, this lack of integration is not merely an organizational issue. It directly affects timeliness, patient experience, and ultimately outcomes.

The opportunity now lies in moving from fragmented capacity to coordinated care — where patients no longer have to bridge the gaps between system components themselves.

Source: Mapping-the-Efficiency-of-Cancer-Care-in-Greece-FINAL

Text/adaptation: Ifiyenia Anastasiou for Kapa3

EOPYY: New reimbursement framework for respiratory devices – What changes for patients

The reimbursement of respiratory devices under EOPYY has been updated through a new decision published in the Government Gazette (FEK) on April 27, 2026.

On April 27, 2026, a new EOPYY decision was published in the Government Gazette, establishing revised reimbursement prices for respiratory devices such as CPAP, Auto CPAP, and BiPAP machines.

These are medical devices primarily used by patients with respiratory disorders, including sleep apnoea, and they represent a fundamental part of daily treatment and quality of life.

EOPYY reimbursement for respiratory devices: what changes

With this regulation:

  • specific reimbursement prices are defined for each category of respiratory device
  • the prices apply to all products included in the Reimbursed Medical Devices Register
  • previous decisions for the same categories are replaced

Prices are unified per device category, regardless of manufacturer or commercial model.

What this means for patients

The new EOPYY reimbursement framework for respiratory devices provides a clearer structure for people living with respiratory conditions who depend on these devices in their daily lives:

  • it clarifies what is covered by EOPYY
  • it strengthens transparency regarding equipment costs
  • it ensures access to essential therapeutic tools that are not a choice, but a necessity

In some cases, a patient co-payment may apply when the device price exceeds the reimbursement amount.

Temporary nature of the regulation

The decision is considered temporary, as it is part of a transitional framework until the completion of the negotiation process for final pricing.

Nevertheless, it is fully applicable from the moment of its publication in the Government Gazette and constitutes the current reimbursement framework.

A more human perspective

Behind technical terms, codes, and regulatory tables, there are people who rely on these devices to breathe better, sleep better, and maintain a more stable daily life.

A clear reimbursement framework is not merely an administrative measure. It helps reduce uncertainty in situations that are already difficult to manage.

Source

The full text of the decision, along with the detailed list of reimbursed respiratory devices and corresponding prices, is available (in Greek) in the Government Gazette (FEK) of April 27, 2026.

Text/adaptation: Ifiyenia Anastasiou for Kapa3

January – Cervical Cancer Awareness Month

January is internationally dedicated to raising awareness about cervical cancer. Known as Cervical Cancer Awareness Month, it aims to highlight the importance of prevention, early detection, and vaccination against the human papillomavirus (HPV), which is responsible for nearly all cases of the disease.

Cervical cancer remains a major public health issue worldwide. According to the World Health Organization, approximately 660,000 new cases are diagnosed globally each year, and more than 350,000 women lose their lives to the disease. It is among the most common cancers affecting women, particularly in regions where access to preventive screening and vaccination is limited. At the same time, it is one of the few cancers that can largely be prevented through organized prevention and early detection programmes.

In Greece, available data indicate that around 700 new cases of cervical cancer are diagnosed annually, while more than 280 deaths are attributed to the disease each year. The estimated incidence is approximately 8 cases per 100,000 women. Although this places Greece close to the European average, it also highlights the need for further improvement in prevention and early diagnosis.

Cervical cancer is closely linked to chronic infection with human papillomavirus (HPV), a very common virus transmitted mainly through sexual contact.

HPV vaccination, combined with regular gynaecological screening through Pap tests and HPV tests, can significantly reduce the development of precancerous lesions and cervical cancer. In this context, the World Health Organization has set the goal of eliminating cervical cancer as a public health problem by 2030, through high vaccination coverage, universal screening, and timely treatment.

January serves as an important reminder that information and prevention save lives. Open discussion around women’s health, free from fear and stigma, empowers women to take care of themselves and to claim prevention as a fundamental right.

Special emphasis should be placed on the systematic education of younger generations, as prevention begins long before any symptoms appear. Access to reliable information, preventive screening services, and vaccination programmes is a key factor in reducing health inequalities and protecting future generations.

At KAPA3, we believe that information and prevention are core pillars of care and empowerment. Through the dissemination of reliable information and the support of initiatives that promote public health, we stand alongside every woman who needs knowledge, prevention, and timely care.

Because cervical cancer can be prevented, we encourage everyone to take action. Give a meaningful gift to the women you care about: daughters, sisters, mothers, friends, partners, spouses. Talk openly about women’s health, share information, support initiatives, challenge taboos, and promote early diagnostic screening.

Information and open dialogue are the strongest tools we have.

Sources:

World Health Organization (WHO)
Cervical cancer – Fact sheet

WHO – Global strategy to accelerate the elimination of cervical cancer

International Agency for Research on Cancer (IARC / WHO)
Cervical Cancer Awareness Month

ICO / IARC HPV Information Centre – Greece Factsheet

Ministry of Health – National Immunization Programme

Hellenic National Public Health Organization (EODY)
HPV and cervical cancer

Text/adaptation: Ifiyenia Anastasiou for Kapa3

Kapa3: Participation in the Alliance for Obesity Prevention and the Release of the First National Clinical Practice Guidelines in Greece

The National Obesity Clinical Practice Guidelines mark a historic milestone for public health in Greece.

Kapa3, an active member of the Alliance for Obesity Prevention (#Action4Obesity), continues to consistently promote the message that prevention, education, and support are vital for the health of all citizens. As part of our participation, we were delighted to contribute to the workshop of the Panhellenic Association for the Support of People with Obesity “Imeroesa” on “Obesity and Cancer – From Theory to Practice”, a participation that highlighted the importance of interdisciplinary collaboration and knowledge exchange.

This participation was part of a broader collaboration that led to a historic milestone for the country: the release of the first National Clinical Practice Guidelines for the Management of Obesity in Greece. At the press conference held on Tuesday, November 25, the completion of these guidelines was announced, marking a landmark achievement for Greece.

The National Clinical Practice Guidelines for the Management of Obesity establish, for the first time, a unified, scientifically evidence-based framework for the prevention, assessment, and therapeutic management of obesity, clearly recognizing it as a chronic disease. This is a project of great significance for society, citizens, and the healthcare system, as it provides critical guidance for addressing a condition that affects a large proportion of the population.

The development of the guidelines took 20 months and involved over 50 experts from 20 different specialties. The project includes 21 chapters, available on the Alliance for Obesity Prevention website, covering the full spectrum of prevention, management, and treatment of the condition. The guidelines provide data on the prevalence of obesity in Greece (almost 70% of the adult population overweight or obese) and internationally, as well as on the impact on healthcare costs, productivity, and mortality.

Alongside the scientific and clinical aspects, the new guidelines highlight the need for social awareness. Obesity is not a matter of personal weakness; individuals living with excess weight often face stigma, discrimination, and social exclusion, affecting their mental health, access to care, and quality of life. The adoption of the National Clinical Practice Guidelines signals not only the recognition of obesity as a disease, but also a clear commitment to respect, equal treatment, and the elimination of all forms of weight-based stigma, promoting a society that is more informed, fair, and supportive for all.

The Alliance for Obesity Prevention now emerges as a key actor in public health, while the active participation of Kapa3 reaffirms our commitment to inform, raise awareness, and support patients, reinforcing the shared vision of a society that values health, prevention, and timely intervention.

Text/adaptation: Ifiyenia Anastasiou for Kapa3